BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 12/31/2014

Position Statistics

Total Positions 79
New Positions 10
Increased Positions 37
Decreased Positions 25
Positions with Activity 62
Sold Out Positions 8
Total Mkt Value (in $ millions) 1,309

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0.63%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial 1.38%
Healthcare 86.82%
Services 0%
Technology
Transportation
Utilities

10 New Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) Change in Value ($1,000s) Change (%) Shares Held ▲
RAPTOR PHARMACEUTICAL CORP COM 180 180 New 15,558
HEARTWARE INTL INC COM 4,446 4,446 New 50,000
MASIMO CORP COM 3,076 3,076 New 97,900
AUSPEX PHARMACEUTICALS INC COM 6,884 6,884 New 100,000
SALIX PHARMACEUTICALS INC COM 17,263 17,263 New 100,000
LIGAND PHARMACEUTICALS INC COM NEW 13,990 13,990 New 199,000
PARATEK PHARMACEUTICALS INC COM 8,207 8,207 New 260,283
ADMA BIOLOGICS INC COM 3,592 3,592 New 389,193
MEDGENICS INC COM NEW 8,436 8,436 New 1,025,000
AMARIN CORP PLC SPONS ADR NEW 5,048 5,048 New 2,233,746